|
| Own Slots | ||
|---|---|---|
| Slot Name | Value | |
 |
Alternatives | |
|
CanImprove | |
|
CautionWithMedicationsUsed | |
|
Comment | |
|
Contraindication | |
|
CouldBeRelatedTo | Cerebral_infarction |
|
Cui | C0012582 |
|
Definition | A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) (MeSH) |
|
DespiteReceivingTreatment | |
|
DoNotUseWithMedicationGroup | |
|
EspeciallyEffectiveAgainst | |
|
Improves | |
|
Incrementsmgday | |
|
InitiatingDose | |
|
MaintenanceDose | |
|
MaximumRecommendedDailyDose | |
|
MeanDailyDose | |
|
RelevantSignOrSymptom | |
|
SideEffect | |
|
Synonyms | |
|
TargetDose | 200 mg + Aspirin 25 mg |
|
TitrationPeriod | |
|
TreatmentStatus | |
|
Treats | |
|
UMLSSynonyms | |
|
UsedTogetherWithMedication | |
|
UsedWithMedicationGroup | |
|
UseWhenExistsIntoleranceOf | |
|
UseWithTest |